As of July 1, 2026, eligible Medicare Part D beneficiaries can access three FDA-approved GLP-1 medications for chronic weight management at a flat $50 per month medication copay
Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL: Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk
These tools can provide valuable assistance as you work towards a healthier, more balanced lifestyle
"Cancel anytime" stops future billing - it doesn't refund charges already processed
The semaglutide syringe dosage conversion chart makes these differences visually clear for quick reference
Results vary, but noticeable weight loss may begin within a few weeks